Calcium folinate pentahydrate
Ampulla of Vater Carcinoma
Alliance for Clinical Trials in OncologySmall moleculePhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Ampulla of Vater Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dostarlimab UNICANCER | Phase 2 | CCC |
FLUOROURACILUM Alliance for Clinical Trials in Oncology | Phase 1 | CC |
Eloxatin Alliance for Clinical Trials in Oncology | N/A | D |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →